Table 2 Localized indolent EBV-associated lymphoproliferative disorder/lymphoma in the eldery
No | Age/Sex | Site | Pathologic diagnosis | HIV infection | Treatment | Outcome | Follow-up(months) | IGH/MYC | Reference No. (case No.) |
|---|---|---|---|---|---|---|---|---|---|
1 | 80/M | Gingiva | PBL-E | - | None | SR | Alive (8) | N | Present case |
2 | 79/M | Skin of check | EBV-MCU | - | None | SR | DNED (25) | NA | 8 (1) |
3 | 82/M | Lip, Skin | EBV-MCU | - | None | SR | NA | NA | 8 (2) |
4 | 76/M | Tongue | EBV-MCU | - | None | SR | Alive (12) | NA | 8 (7) |
5 | 68/F | Tongue | EBV-MCU | - | None | SR | Alive (36) | NA | 8 (13) |
6 | 88/M | Skin of chest | EBV-MCU | - | None | SR | Alive (3) | NA | 8 (16) |
7 | 64/M | Nasal cavity | PBL-E | - | CHOP + RT | CR | Alive (55) | N | 3 (4) |
8 | 70/M | Gingiva | PBL-E | - | CHOP | CR | Alive (23) | R | 3 (6) |
9 | 60/M | Nasal cavity | PBL-E | - | CHOP | Under therapy | Alive (1) | N | 3 (8) |